0591-2533 : Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release


NDC0591-2533
Labeler: Actavis Pharma, Inc.
Product Type: Human Prescription Drug
Drug Name:  Dalfampridine
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: ANDA206836
Rev. Date: 


NDC Package Codes:

  • 0591-2533-60: 60 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (0591‑2533‑60)

Active Ingredients:

  • Dalfampridine

Dosage Strength:

  • 10 mg

Pharmaceutical Classes:

  • Potassium Channel Antagonists [MoA]
  • Potassium Channel Blocker [EPC]

Related Products:

Based on records with the same trade name.
  • 0054-0479 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by West-ward Pharmaceuticals Corp.
  • 0378-0509 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-4504 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 16729-292 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by Accord Healthcare Inc.
  • 42571-275 Dalfampridine 10 mg Oral Tablet, Extended Release by Micro Labs Limited
  • 51407-246 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by Golden State Medical Supply, Inc.
  • 62756-429 Dalfampridine 10 mg Oral Tablet, Extended Release by Sun Pharmaceutical Industries, Inc.
  • 63629-9450 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by Bryant Ranch Prepack
  • 65862-863 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by Aurobindo Pharma Limited
  • 67877-444 Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release by Ascend Laboratories, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0591-2533 QR Code

< Prev: 0591-2529Next: 0591-2562 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.